EKSO Q2 2020 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M-30.6% YoY

Gross Profit

$1M55.6% margin

Operating Income

-$3M-136.6% margin

Net Income

-$12M-519.7% margin

EPS (Diluted)

$-1.88

QoQ Revenue Growth

+54.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$530,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$22M

Stockholders' Equity

-$28,000

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-30.6%
Gross Profit	$1M	$2M	-19.3%
Operating Income	-$3M	-$5M	+39.3%
Net Income	-$12M	-$3M	-283.8%

Revenue Segments

EksoHealth

$2M92%

EksoWorks

$178,0008%

Geographic Segments

UNITED STATES

$2M72%

Non-US

$624,00028%